[1]Patent:CN106905241,2017,A,.Locationinpatent:Paragraph0133-0135
[2]Patent:CN107118249,2017,A,.Locationinpatent:Paragraph0132;0133;0134
[3]BiochemischeZeitschrift,1956,vol.327,p.422,447
[1]BiochemischeZeitschrift,1956,vol.327,p.422,447
[2]Patent:CN106905241,2017,A,
[3]Patent:CN107118249,2017,A,
[1]PhotochemicalandPhotobiologicalSciences,2014,vol.13,#2,p.310-315
[1]AustralianJournalofChemistry,1982,vol.35,#4,p.775-784
[1]Patent:CN106905241,2017,A.Locationinpatent:Paragraph0133-0135
[2]Patent:CN107118249,2017,A.Locationinpatent:Paragraph0132;0133;0134
[3]BiochemischeZeitschrift,1956,vol.327,p.422,447
[4]Molecules,2019,vol.24
[1]JournalofMedicinalChemistry,1982,vol.25,p.1342-1346
[1]PolishJournalofChemistry,1984,vol.58,p.149-156
[1]AustralianJournalofChemistry,1982,vol.35,p.775-784
[1]AustralianJournalofChemistry,1982,vol.35,p.775-784
Title: Disposition and drug-drug interaction potential of veliparib (ABT-888), a novel and potent inhibitor of poly(ADP-ribose) polymerase.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20110701
Title: Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives.
Journal: European journal of medicinal chemistry 20110101
Title: Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studies.
Journal: Peptides 20061201
Title: Benzimidazole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.
Journal: Bioorganic & medicinal chemistry letters 20060901
Title: Conversion of the potent delta-opioid agonist H-Dmt-Tic-NH-CH(2)-bid into delta-opioid antagonists by N(1)-benzimidazole alkylation(1).
Journal: Journal of medicinal chemistry 20051229
Title: Synthesis and antimicrobial activity of some new 2-phenyl-N-substituted carboxamido-1H-benzimidazole derivatives.
Journal: Archiv der Pharmazie 20010501